John D. Seigne

6.0k total citations · 2 hit papers
113 papers, 4.4k citations indexed

About

John D. Seigne is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, John D. Seigne has authored 113 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Surgery, 43 papers in Oncology and 25 papers in Pulmonary and Respiratory Medicine. Recurrent topics in John D. Seigne's work include Bladder and Urothelial Cancer Treatments (45 papers), Urinary and Genital Oncology Studies (19 papers) and Colorectal Cancer Screening and Detection (16 papers). John D. Seigne is often cited by papers focused on Bladder and Urothelial Cancer Treatments (45 papers), Urinary and Genital Oncology Studies (19 papers) and Colorectal Cancer Screening and Detection (16 papers). John D. Seigne collaborates with scholars based in United States, Lebanon and Spain. John D. Seigne's co-authors include Sam S. Chang, Eila C. Skinner, Raj S. Pruthi, Julio M. Pow‐Sang, J. Stuart Wolf, M. Craig Hall, Guido Dalbagni, Paul F. Schellhammer, Diane Zipursky Quale and Badrinath R. Konety and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

John D. Seigne

108 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline

2016 937 citations John D. Seigne et al. profile →
Guideline for the Management of Nonmuscle Invasive Bladder Cancer (Stages Ta, T1, and Tis): 2007 Update

2007 646 citations John D. Seigne et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John D. Seigne United States	29	2.2k	1.2k	1.1k	761	760	113	4.4k
Julio M. Pow‐Sang United States	38	1.7k 0.8×	1.3k 1.0×	1.1k 1.0×	1.3k 1.7×	702 0.9×	214	4.7k
D. Robert Siemens Canada	38	1.3k 0.6×	1.4k 1.2×	1.0k 0.9×	1.3k 1.7×	439 0.6×	219	5.1k
Howard Kynaston United Kingdom	32	1.2k 0.5×	914 0.7×	1.2k 1.1×	1.3k 1.7×	482 0.6×	111	4.0k
Simon Tanguay Canada	40	2.1k 0.9×	816 0.7×	1.5k 1.4×	2.4k 3.1×	706 0.9×	213	4.7k
María J. Ribal Spain	37	5.5k 2.4×	1.5k 1.2×	1.6k 1.5×	1.8k 2.4×	2.0k 2.6×	178	7.6k
Peter J. Boström Finland	33	1.5k 0.7×	597 0.5×	656 0.6×	1.5k 1.9×	530 0.7×	183	3.7k
Theo M. de Reijke Netherlands	40	2.6k 1.2×	969 0.8×	1.3k 1.2×	3.7k 4.9×	830 1.1×	189	7.5k
Christer Busch Sweden	33	2.6k 1.1×	1.3k 1.0×	1.3k 1.2×	3.5k 4.6×	700 0.9×	106	6.8k
Ganesh S. Palapattu United States	41	2.9k 1.3×	1.3k 1.0×	1.6k 1.5×	2.7k 3.5×	1.1k 1.4×	185	6.5k
William A. See United States	34	1.7k 0.7×	599 0.5×	621 0.6×	1.6k 2.1×	387 0.5×	179	3.8k

Countries citing papers authored by John D. Seigne

Since Specialization

Citations

This map shows the geographic impact of John D. Seigne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John D. Seigne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John D. Seigne more than expected).

Fields of papers citing papers by John D. Seigne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John D. Seigne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John D. Seigne. The network helps show where John D. Seigne may publish in the future.

Co-authorship network of co-authors of John D. Seigne

This figure shows the co-authorship network connecting the top 25 collaborators of John D. Seigne. A scholar is included among the top collaborators of John D. Seigne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John D. Seigne. John D. Seigne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Ji‐Qing, Lucas A. Salas, John K. Wiencke, et al.. (2023). Genome-Scale Methylation Analysis Identifies Immune Profiles and Age Acceleration Associations with Bladder Cancer Outcomes. Cancer Epidemiology Biomarkers & Prevention. 32(10). 1328–1337. 9 indexed citations

Chen, Ji‐Qing, Lucas A. Salas, John K. Wiencke, et al.. (2022). Immune profiles and DNA methylation alterations related with non-muscle-invasive bladder cancer outcomes. Clinical Epigenetics. 14(1). 14–14. 20 indexed citations

Abdollahi, Behnaz, Manu Goyal, Matthew A. Suriawinata, et al.. (2022). Bladder cancer prognosis using deep neural networks and histopathology images. Journal of Pathology Informatics. 13. 100135–100135. 19 indexed citations

Citters, Douglas W. Van, et al.. (2022). A particle filter approach to dynamic kidney pose estimation in robotic surgical exposure. International Journal of Computer Assisted Radiology and Surgery. 17(6). 1079–1089. 5 indexed citations

Barth, Richard J., Julia L. Kelly, Sarah Y. Bessen, et al.. (2021). Reasons for Long-term Opioid Prescriptions After Guideline-directed Opioid Prescribing and Excess Opioid Pill Disposal. Annals of Surgery. 277(1). 173–178. 10 indexed citations

Rezaee, Michael E., et al.. (2021). Partial Versus Complete Bacillus Calmette-Guérin Intravesical Therapy and Bladder Cancer Outcomes in High-risk Non–muscle-invasive Bladder Cancer: Is NIMBUS the Full Story?. European Urology Open Science. 26. 35–43. 5 indexed citations

Rezaee, Michael E., et al.. (2020). Mischievous malakoplakia: A potential pitfall of mpMRI of the prostate?. Urology Case Reports. 32. 101222–101222. 1 indexed citations

Reeves, J. Jeffery, Andrew R. Forauer, John D. Seigne, & Elias S. Hyams. (2015). Image-Guided Embolization Coil Placement for Identification of an Endophytic, Isoechoic Renal Mass During Robotic Partial Nephrectomy. Journal of Endourology Case Reports. 1(1). 59–61. 4 indexed citations

Ingimarsson, Johann P., et al.. (2015). Immunoglobulin G4‐related disease in the urinary bladder. International Journal of Urology. 22(6). 605–607. 9 indexed citations

10.

Ingimarsson, Johann P., et al.. (2015). A single-centre experience with tumour tract seeding associated with needle manipulation of renal cell carcinomas. Canadian Urological Association Journal. 9(11-12). 890–890. 17 indexed citations

11.

Wan, Yuqing, Andrea Borsic, John Heaney, et al.. (2013). Transrectal electrical impedance tomography of the prostate: Spatially coregistered pathological findings for prostate cancer detection. Medical Physics. 40(6Part1). 63102–63102. 16 indexed citations

12.

Marotti, Jonathan D., John D. Seigne, & Edward J. Gutmann. (2011). Presence of benign germ cells in a fine needle aspirate of a spermatocele. Diagnostic Cytopathology. 41(4). 342–343. 1 indexed citations

13.

Fishman, Mayer, Terri Hunter, Hatem Soliman, et al.. (2008). Phase II Trial of B7-1 (CD-86) Transduced, Cultured Autologous Tumor Cell Vaccine Plus Subcutaneous Interleukin-2 for Treatment of Stage IV Renal Cell Carcinoma. Journal of Immunotherapy. 31(1). 72–80. 52 indexed citations

14.

Dessureault, Sophie, Marwan Alsarraj, Susan McCarthy, et al.. (2005). A GM-CSF/CD40L Producing Cell Augments Anti-tumor T Cell Responses. Journal of Surgical Research. 125(2). 173–181. 16 indexed citations

15.

Rosenberg, Jonathan E., Hans von der Maase, John D. Seigne, et al.. (2005). A phase II trial of R115777, an oral farnesyl transferase inhibitor, in patients with advanced urothelial tract transitional cell carcinoma. Cancer. 103(10). 2035–2041. 42 indexed citations

16.

Kumar, Nagi B., Alan Cantor, Kathy Allen, et al.. (2003). The specific role of isoflavones in reducing prostate cancer risk. The Prostate. 59(2). 141–147. 117 indexed citations

17.

Moreira, Sergio G., John D. Seigne, Raul Ordorica, et al.. (2003). Devastating complications after brachytherapy in the treatment of prostate adenocarcinoma. British Journal of Urology. 93(1). 31–35. 66 indexed citations

18.

Seigne, John D., Scott Antonia, & Mayer Fishman. (2001). Novel therapies for renal cell carcinoma. Expert Opinion on Investigational Drugs. 10(6). 1033–1044. 10 indexed citations

19.

Diaz, José I., et al.. (2000). Cytometric analysis of Fas and Bcl-2 expression in normal prostatic epithelium and prostate cancer. Urologic Oncology Seminars and Original Investigations. 5(4). 149–154. 12 indexed citations

20.

Antonia, Scott & John D. Seigne. (2000). B7-1 gene-modified autologous tumor-cell vaccines for renal-cell carcinoma. World Journal of Urology. 18(2). 157–163. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact